España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Isaac Ro
Notable Sema4 Holdings Insider Trades $165K In Company Stock
Chief Financial Officer Of Sema4 Holdings Trades $305K In Company Stock
Hologic: Meet Goldman Sach's New 'Conviction Buy'
Chief Financial Officer Of Sema4 Holdings Trades $305K In Company Stock
Hologic: Meet Goldman Sach's New 'Conviction Buy'
Goldman Bullish On Agilent Technologies, Raises Price Target To $53
Goldman Keeps Agilent On Conviction Buy List Following Mixed Q3, Light Guidance
Goldman Bullish On Agilent Technologies, Raises Price Target To $53
Goldman Keeps Agilent On Conviction Buy List Following Mixed Q3, Light Guidance
Goldman Believes Key Update On Exact Sciences Reimbursement 'Appears Imminent'
Goldman Adds Agilent To Conviction List: 'EPS Drivers Are Underappreciated'
Read More...
Isaac Ro Recent News
Goldman Removes Hologic From Conviction Buy List, Maintains Buy
Goldman Upgrades Agilent Technologies, FEI Company And Myriad Genetics
Goldman Just Downgraded These Three Life Science Stocks
Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere
Numerous Analysts Bullish On VWR Following Quiet Period Expiration
UPDATE: Goldman Sachs Upgrades Thermo Fisher Scientific as End Market Dynamics Improve
UPDATE: Goldman Sachs Initiates on FEI On Expectations Of Shares To Perform In Line With LST Coverage
UPDATE: Goldman Sachs Initiates Coverage on Pall Corp, In-Line Performance Expected
UPDATE: Goldman Sachs Raises PT on Agilent Technologies Following F3Q Revenue/EPS Report
UPDATE: Goldman Sachs Raises PT on Illumina on BaseSpace Thoughts
Life Technologies Corp. (LIFE) Maintains Outperform Rating
Leerink Swann Suspends Millipore (MIL) Rating After Acquisition Announced